U.S. Gastroenterology Devices Market to Reach $41.2B

Market Outlook

By 2035, the U.S. Gastroenterology Devices Market is expected to reach approximately USD 41.20 billion, expanding at a CAGR of 7.85% during the forecast period 2026–2035. The market was valued at USD 19.35 billion in 2025, while the historical market increased from an estimated USD 13.78 billion in 2021 to USD 17.88 billion in 2024. The market is projected to reach approximately USD 20.87 billion in 2026. Values in this report are expressed in USD billions.

The market sizing scope includes capital equipment, reusable and single-use endoscopes, visualization platforms, therapeutic endoscopy accessories, endoscopic ultrasound and ERCP devices, enteral feeding products, capsule endoscopy, gastrointestinal motility and reflux testing systems, liver stiffness assessment platforms, endoscopic bariatric devices, and selected reflux-intervention technologies. It excludes pharmaceuticals, laboratory-only diagnostics, hospital and physician service revenue, general-purpose surgical equipment not specifically attributable to gastroenterology, and non-device consumables that cannot be reliably assigned to a gastrointestinal procedure.

The U.S. gastroenterology devices industry is supported by a large and recurring clinical need across colorectal cancer screening, gastroesophageal reflux disease, inflammatory bowel disease, gastrointestinal bleeding, pancreaticobiliary disorders, chronic liver disease, obesity, motility disorders, and nutrition support. Official U.S. cancer statistics recorded 147,931 new colorectal cancers in 2022 and 53,779 colorectal cancer deaths in 2023. At the same time, only about 61% of adults aged 45–75 were up to date with recommended colorectal cancer screening in 2022, leaving a substantial pool of eligible but unscreened patients. This screening gap is commercially important because positive stool-based or blood-based screening results frequently lead to diagnostic colonoscopy and therapeutic polypectomy.

Demand is also being reshaped by demographic and site-of-care change. The U.S. population aged 65 and older reached approximately 61.2 million in 2024, and one in five Americans is projected to be of retirement age by 2030. Older patients generate disproportionate demand for colonoscopy, upper endoscopy, ERCP, EUS, enteral feeding, dysphagia management, GI bleeding intervention, liver assessment, and surveillance of premalignant conditions. Meanwhile, endoscopy is increasingly delivered in ambulatory surgery centers and freestanding endoscopy facilities, creating a larger addressable market for compact capital platforms, disposable accessories, single-use scopes, efficient reprocessing systems, and workflow software.

The historical market recovered strongly after the pandemic-era disruption of elective procedures. Growth from 2021 through 2024 was supported by restored colonoscopy backlogs, renewed hospital capital spending, expansion of ambulatory endoscopy capacity, adoption of AI-assisted polyp detection, higher use of endoscopic ultrasound and advanced therapeutic endoscopy, and broader deployment of single-use components in selected procedures. In 2025, purchasing priorities shifted from simple replacement of aging towers toward integrated platforms that can improve lesion detection, support advanced therapy, reduce room turnover time, standardize documentation, and lower total procedure cost.

Introduction

According to the U.S. Gastroenterology Devices Market Report, the market combines high-volume screening activity with complex interventional procedures and long-duration chronic disease management. Gastroenterology is unusually device-intensive because the clinical pathway often begins with visualization or physiologic measurement and can proceed immediately to biopsy, resection, hemostasis, dilation, stenting, ablation, drainage, suturing, feeding access, or surveillance. This creates a diversified revenue pool that includes capital systems, reusable equipment, single-use scopes, procedure-specific disposables, implants, software, service contracts, and replacement accessories.

The market is not limited to conventional colonoscopy and upper GI endoscopy. It extends across endoscopic ultrasound, endoscopic retrograde cholangiopancreatography, capsule endoscopy, pH and impedance monitoring, high-resolution manometry, anorectal diagnostics, liver elastography, enteral feeding, endoscopic bariatric therapy, transoral reflux procedures, endoscopic submucosal dissection, full-thickness resection, and management of GI bleeding or luminal obstruction. These categories have different growth rates, purchasing channels, training requirements, and reimbursement profiles, which makes market analysis dependent on procedure-level modeling rather than broad device-category assumptions.

The U.S. care-delivery environment provides substantial commercial capacity. Hospital expenditures reached approximately USD 1.63 trillion in 2024, while the number of Medicare-certified ambulatory surgery centers reached about 6,436 in 2024. Gastroenterology remains one of the most common service lines in ASCs because screening colonoscopy, diagnostic upper endoscopy, biopsy, polypectomy, dilation, and selected therapeutic procedures can be completed without inpatient admission. The economics of these settings favor products that reduce preparation time, minimize capital footprint, improve daily case throughput, and simplify infection-control compliance.

Hospital procurement behavior is becoming more disciplined. Large health systems increasingly evaluate endoscopy equipment through enterprise value-analysis committees that examine five-year ownership cost, scope durability, repair expense, reprocessing labor, interoperability, image quality, physician preference, cybersecurity, and standardization across hospital and ambulatory sites. A high-definition processor or therapeutic platform is therefore rarely purchased as an isolated device. It is assessed as part of a broader ecosystem that may include scopes, accessories, service contracts, software, AI modules, reprocessors, storage, training, and data integration.

The U.S. market also has a structural tension between procedure growth and workforce capacity. Screening eligibility expanded to average-risk adults beginning at age 45, advanced endoscopy indications continue to broaden, and chronic GI disease prevalence is rising. However, endoscopy room capacity, trained nursing staff, anesthesia availability, reprocessing labor, and specialist supply remain constrained in many markets. Devices that allow more procedures per room, make quality less operator-dependent, reduce repeat procedures, or shift appropriate care to ambulatory settings therefore have economic value beyond their acquisition price.

From 2026 to 2035, the defining strategic transition will be from isolated visualization tools to connected diagnostic and therapeutic platforms. The strongest vendors will combine image enhancement, AI support, advanced accessories, documentation, quality measurement, training, and service reliability. The market will reward technologies that detect clinically significant lesions earlier, allow definitive therapy during the same encounter, reduce adverse events, and produce data that can support reimbursement, accreditation, and value-based contracting.

Key Market Drivers: What’s Fueling the U.S. Gastroenterology Devices Market Boom?

The first major driver is the persistent burden of colorectal cancer and the unfinished screening opportunity. Colorectal cancer remains a major source of mortality and treatment expenditure in the United States. Screening can identify cancer earlier and can prevent disease through removal of precancerous polyps, yet a large portion of screening-eligible adults remains overdue. Lowering the routine screening threshold to age 45 expanded the addressable population and increased the need for colonoscopy, disposable snares, forceps, retrieval devices, clips, insufflation systems, reprocessing capacity, and AI-assisted detection. The commercial effect is not limited to screening procedures; it also extends to surveillance colonoscopy among patients with prior adenomas, inflammatory bowel disease, genetic risk, or previous colorectal cancer.

A second driver is the breadth of chronic digestive disease. Researchers estimate that gastroesophageal reflux disease affects about one-fifth of the U.S. population. Inflammatory bowel disease affects an estimated 2.4 million to 3.1 million people, and annual U.S. healthcare costs attributed to IBD were approximately USD 8.5 billion in 2018. These conditions require repeated diagnostic evaluation, mucosal surveillance, stricture management, bleeding control, motility testing, pH monitoring, nutrition support, and sometimes surgery-sparing endoscopic intervention. Chronic disease creates recurring utilization rather than one-time device demand, making it strategically attractive for manufacturers with portfolios spanning diagnosis, therapy, and follow-up.

A third driver is population aging. The U.S. population aged 65 and older is expanding faster than the overall population and reached approximately 18% of residents in 2024. Aging increases the prevalence of colorectal neoplasia, dysphagia, diverticular disease, GI bleeding, pancreaticobiliary obstruction, motility disorders, malnutrition, and comorbidities that can make open surgery less desirable. This supports demand for minimally invasive endoscopic therapy, enteral access, single-session diagnosis and treatment, and devices that can be used safely in high-risk patients.

A fourth driver is obesity and metabolic disease. Adult obesity prevalence was approximately 40.3% during August 2021–August 2023, while severe obesity affected about 9.4% of adults. Obesity increases demand for reflux evaluation, liver stiffness assessment, metabolic and bariatric intervention, anesthesia-intensive endoscopy, and management of obesity-associated gastrointestinal and hepatobiliary disease. The device opportunity is broadening from conventional bariatric surgery toward endoscopic sleeve gastroplasty, intragastric therapies, endoscopic suturing, mucosal therapies, and minimally invasive management of postoperative complications.

A fifth driver is the migration of procedures to ambulatory settings. The number of Medicare-certified ASCs increased to approximately 6,436 in 2024, and procedure volume per fee-for-service Medicare beneficiary has continued to rise. Gastroenterology is a core ASC specialty because many procedures have predictable duration, established reimbursement, and low need for overnight admission. For manufacturers, this shifts product design toward smaller footprints, faster setup, predictable maintenance, disposable or semi-disposable components, and pricing models that fit physician-owned or joint-venture facilities. It also increases the importance of distribution, field service, training, and inventory management outside major hospitals.

A sixth driver is hospital focus on total procedure economics. U.S. hospitals face high labor costs, constrained operating margins, and pressure to improve throughput without compromising quality. Procurement committees increasingly calculate the cost of scope repair, reprocessing, delayed starts, cancelled cases, accessory waste, procedure duration, readmissions, infection risk, and repeat intervention. A product with a higher unit price can gain adoption if it reduces room turnover, enables same-session therapy, decreases repeat procedures, or supports migration from inpatient to outpatient care. This favors integrated platforms and clinically differentiated disposables over undifferentiated commodity devices.

A seventh driver is reimbursement and quality measurement. Medicare and commercial payers continue to support a broad range of endoscopic procedures, but site-of-service economics influence purchasing. For many services, ASC payment rates remain materially below hospital outpatient rates, which intensifies cost discipline in ambulatory facilities. At the same time, colonoscopy quality measures, documentation requirements, and surveillance-interval standards encourage investment in software, AI, image capture, and structured reporting. Vendors that help facilities demonstrate adenoma detection, withdrawal-time compliance, complete examination, and appropriate follow-up can strengthen their role in the clinical workflow.

An eighth driver is the expansion of advanced therapeutic endoscopy. Endoscopic ultrasound-guided drainage, ERCP, cholangioscopy, endoscopic mucosal resection, endoscopic submucosal dissection, full-thickness resection, closure, suturing, ablation, and stenting are allowing gastroenterologists to treat conditions that previously required surgery or interventional radiology. These procedures support premium-priced accessories and specialized capital equipment. They also create barriers to entry because adoption depends on physician training, referral patterns, credentialing, and multidisciplinary coordination.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. gastroenterology devices market is increasingly focused on improving detection, enabling definitive treatment, reducing infection risk, and making endoscopy more operationally efficient. The competitive benchmark is no longer basic image resolution. Buyers expect a platform to provide enhanced visualization, compatibility with therapeutic scopes, AI readiness, reliable data capture, manageable repair economics, and a clear upgrade path.

AI-assisted colonoscopy is one of the most visible innovation cycles. The first FDA-authorized computer-aided polyp detection platform established a new product category, and additional systems received U.S. clearances during 2024 and 2025. These technologies analyze live colonoscopy video and alert the endoscopist to areas that may contain polyps or mucosal lesions. The near-term value proposition is improved consistency and support for lesion detection, particularly across mixed-experience physician groups. The longer-term opportunity includes lesion characterization, automated quality documentation, procedural analytics, and integration with pathology and surveillance recommendations. Adoption will depend on evidence that the technology improves clinically meaningful outcomes without generating excessive false alerts or workflow burden.

Image-enhanced endoscopy is also advancing. New platforms combine high-definition or 4K visualization with multiple light modes, narrow-band or linked-color approaches, texture and contrast enhancement, and digital zoom. These capabilities can improve recognition of subtle mucosal abnormalities and support targeted biopsy or resection. U.S. health systems increasingly evaluate image enhancement as part of an enterprise platform decision because the same processor may need to support screening, inflammatory bowel disease surveillance, Barrett’s esophagus assessment, ERCP, EUS, and advanced resection.

Single-use endoscopy is creating a parallel innovation cycle. Disposable duodenoscopes, bronchoscopes used in selected GI workflows, gastroscopes, and other single-use components are designed to reduce reprocessing complexity and cross-contamination risk. The strongest use cases are procedures with challenging reprocessing, urgent off-site use, immunocompromised patients, or facilities without high-volume reprocessing infrastructure. The economics are case-dependent: high-volume centers may continue to favor reusable scopes, while lower-volume or high-risk settings may value predictable per-procedure cost and immediate availability. Hybrid fleets are likely to become more common than complete replacement of reusable systems.

Advanced therapeutic endoscopy is moving toward multifunctional devices. New instruments support grasping, cutting, coagulation, dissection, traction, closure, suturing, and defect management through fewer device exchanges. This is important because device exchanges add time, require coordination, and can increase procedural complexity. Technologies that enable en bloc lesion removal, durable closure, or same-session management of complications can improve the economics of endoscopic mucosal resection and submucosal dissection programs.

Endoscopic ultrasound and pancreaticobiliary intervention are becoming more integrated. EUS is increasingly used not only for diagnosis and biopsy but also for drainage, access, tissue acquisition, and therapeutic guidance. Lumen-apposing metal stents, fine-needle biopsy devices, cholangioscopy systems, guidewires, retrieval tools, lithotripsy, and dedicated electrosurgical accessories are expanding the procedure set available to advanced endoscopists. This category is attractive because it combines high-acuity clinical need with recurring premium consumables.

Endobariatric and reflux technologies are another important innovation area. Endoscopic suturing, tissue apposition, mucosal ablation, transoral fundoplication, and metabolic endoscopy platforms are being developed to fill the treatment gap between medication and surgery. Their adoption depends on durable weight loss or symptom control, payer coverage, physician training, and scalable referral pathways. Manufacturers that can pair devices with patient selection, training, coding support, and longitudinal outcomes collection will be better positioned than companies offering a stand-alone procedure tool.

Manufacturers are also innovating around reprocessing, service, and sustainability. Scope repair and reprocessing are major ownership-cost drivers. Newer platforms emphasize leak testing, automated tracking, drying, traceability, and process standardization. Health systems are increasingly comparing reusable and single-use technologies through full lifecycle analysis that includes water, chemicals, labor, repair, waste, and infection-control requirements. Sustainability claims will need to be supported by facility-specific data because the environmental balance varies by procedure volume and reprocessing efficiency.

Segmentation Insights

The U.S. Gastroenterology Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

By Product Category

Gastrointestinal endoscopy systems represent the largest product category by value. This segment includes video processors, light sources, integrated towers, flexible gastroscopes, colonoscopes, duodenoscopes, echoendoscopes, enteroscopes, rigid GI visualization equipment, insufflation, irrigation, image capture, and related accessories. Demand is driven by replacement cycles, expansion of endoscopy rooms, adoption of advanced imaging, and standardization across integrated delivery networks. Market share is influenced by installed base, physician familiarity, service quality, scope durability, and compatibility with therapeutic devices. Premium growth is concentrated in AI-ready processors, 4K or enhanced imaging, compact systems for ambulatory sites, and platforms that support both routine and advanced procedures.
Therapeutic endoscopy devices form the fastest-growing product category. The segment includes snares, biopsy forceps, hemostasis clips, injection needles, dilation balloons, guidewires, retrieval devices, electrosurgical knives, ablation probes, closure systems, suturing platforms, enteral and biliary stents, cholangioscopy accessories, EUS needles, lumen-apposing metal stents, and full-thickness resection tools. Growth is supported by rising procedure complexity and the shift from surgery toward endoscopic treatment. Recurring single-use consumption makes this segment commercially attractive, while product differentiation depends on deliverability, hemostatic performance, visibility, deployment accuracy, and compatibility with existing scopes.
Enteral feeding and nutrition-support devices provide a stable, clinically essential revenue base. This category includes nasogastric and nasoenteric tubes, gastrostomy and gastrojejunostomy devices, low-profile feeding buttons, placement systems, pumps, sets, connectors, and accessories. Demand comes from hospitals, long-term care, home care, oncology, neurology, pediatrics, and patients with swallowing impairment or prolonged nutritional needs. Growth is less dependent on elective procedure cycles than endoscopy capital equipment. Competitive success depends on secure connectors, ease of placement, clog resistance, skin-site management, patient comfort, caregiver training, and reliable home-distribution support.
Gastrointestinal diagnostic and motility devices include capsule endoscopy, pH and impedance monitoring, high-resolution esophageal and anorectal manometry, breath testing systems, wireless motility tools, liver elastography, and related software. This category benefits from a large pool of patients with reflux, unexplained bleeding, dysphagia, functional bowel symptoms, IBD, and chronic liver disease. Growth is supported by the need for objective physiologic data before surgery or long-term therapy. The segment is increasingly software-driven, with value shifting toward automated analysis, cloud review, standardized interpretation, and integration with electronic medical records.
Bariatric, metabolic, and reflux-intervention devices are a smaller but high-growth product category. The segment includes endoscopic suturing systems, intragastric devices, transoral fundoplication tools, mucosal ablation and remodeling platforms, tissue apposition devices, and accessories used to manage bariatric complications. The U.S. obesity burden creates a large theoretical patient pool, but commercial penetration remains constrained by reimbursement variability, physician training, patient awareness, and the need for durable outcomes. The most successful technologies will occupy a clear clinical position between medication and surgery and will be supported by structured aftercare.

By Application

Colorectal cancer screening, surveillance, and lower-GI intervention represent the largest application segment. This area includes screening and diagnostic colonoscopy, biopsy, polypectomy, mucosal resection, bleeding control, stricture dilation, decompression, stenting, and surveillance of high-risk patients. Demand is supported by the large screening-eligible population, the shift to screening from age 45, and the continuing gap between recommended and completed screening. Device growth is concentrated in AI-assisted detection, enhanced imaging, cold-snare techniques, closure, advanced resection, and efficient disposable accessories. The segment also benefits from recurring surveillance procedures after adenoma removal or cancer treatment.
Upper-GI diagnosis and therapy include evaluation and treatment of reflux, Barrett’s esophagus, dysphagia, ulcers, upper-GI bleeding, gastric lesions, varices, and luminal obstruction. With GERD affecting an estimated one-fifth of the U.S. population, the diagnostic pool is substantial. The device mix includes gastroscopes, biopsy and hemostasis tools, dilation balloons, ablation systems, pH testing, manometry, stents, and reflux-intervention platforms. Growth is being driven by same-session diagnosis and therapy, improved bleeding control, Barrett’s surveillance, and demand for objective testing before antireflux procedures.
Pancreaticobiliary and advanced endoscopy applications are among the highest-value areas per procedure. This segment includes ERCP, EUS, cholangioscopy, pancreatic and biliary stenting, stone extraction, lithotripsy, drainage, tissue acquisition, and management of complex strictures or fluid collections. Procedure volumes are concentrated in tertiary hospitals and high-volume referral centers, but technology is gradually diffusing into larger community systems. Vendors compete through device reliability, guidewire performance, access, imaging quality, deployment control, and the ability to support advanced training.
Inflammatory bowel disease, GI bleeding, and small-bowel evaluation form a recurring application segment. Patients with Crohn’s disease or ulcerative colitis may require repeated colonoscopy, enteroscopy, capsule endoscopy, dilation, biopsy, hemostasis, and cancer surveillance. Overt or occult bleeding supports demand for clips, thermal devices, powders, injection systems, capsule imaging, and deep-enteroscopy tools. The commercial opportunity is strengthened by the chronic nature of IBD and the high cost of hospitalization or surgery when disease is not adequately monitored. Technologies that reduce repeat procedures or provide more complete small-bowel assessment have strong clinical relevance.
Obesity, metabolic disease, nutrition, and reflux management represent a rapidly developing application cluster. Adult obesity prevalence above 40% creates demand for endoscopic bariatric treatment, liver assessment, reflux diagnostics, and enteral nutrition. The device pathway can span patient selection, procedure, closure, follow-up, and management of complications. Adoption will be strongest where health systems can build multidisciplinary programs involving gastroenterology, bariatric surgery, nutrition, behavioral health, and obesity medicine. Reimbursement and longitudinal outcomes will determine whether this segment reaches broad community penetration.

By End User

Hospitals and integrated health systems are the dominant end users by value. They purchase high-end visualization platforms, EUS and ERCP systems, advanced therapeutic devices, enteral feeding products, reprocessing equipment, and enterprise software. Academic and tertiary hospitals are the principal sites for complex pancreaticobiliary intervention, advanced resection, management of severe bleeding, and high-risk patients. Large systems increasingly standardize vendors across facilities, negotiate multi-year contracts, and require evidence on ownership cost, repair, infection control, and clinical outcomes. Hospitals also serve as training hubs that influence adoption in affiliated ambulatory centers.
Ambulatory surgery centers and freestanding endoscopy centers are the fastest-growing end-user category. The United States had approximately 6,436 Medicare-certified ASCs in 2024, and gastroenterology is one of the most common ASC specialties. These facilities prioritize daily case throughput, rapid room turnover, predictable per-case cost, compact equipment, and reliable service. Because reimbursement is generally lower than in hospital outpatient departments, purchasing decisions are highly sensitive to consumable cost, repair expense, staffing, and downtime. Single-use accessories, efficient reprocessing, and subscription or leasing models can gain traction when they reduce operational volatility.
Gastroenterology specialty clinics and physician offices are important for reflux testing, motility studies, capsule endoscopy, liver stiffness assessment, follow-up, and selected office-based procedures. These users often lack the capital budgets and biomedical engineering support of hospitals. They value devices that are easy to operate, require limited infrastructure, integrate with practice software, and generate interpretable reports. Vendor education and reimbursement support are important because office economics depend on correct coding, efficient patient scheduling, and low repeat-test rates.
Diagnostic laboratories and specialized motility centers represent a smaller but strategically important end-user group. They perform pH impedance studies, manometry, breath testing, capsule interpretation, and physiologic assessment used to guide medication, surgery, or endoscopic treatment. The value proposition is increasingly based on software, analytics, remote review, and standardized reporting. Consolidation among specialty practices may create larger regional testing networks that can support higher-end platforms and centralized interpretation.
Home healthcare, long-term care, and post-acute providers are central to enteral feeding and nutrition-support demand. These settings require pumps, feeding sets, low-profile devices, connectors, replacement accessories, and caregiver education. Purchasing is influenced by payer coverage, distribution reach, product availability, safety, and ease of use. Growth is supported by earlier discharge, aging, neurologic disease, oncology care, and preference for home management when clinically appropriate. Manufacturers with dependable supply chains and patient-support programs have an advantage over suppliers competing only on unit price.

By Technology Type

Reusable capital platforms remain the largest technology type by value. High-definition processors, reusable scopes, ultrasound platforms, reprocessors, and associated service contracts are embedded in hospital and ASC infrastructure. Their economics depend on utilization, repair frequency, reprocessing cost, and lifecycle duration. Large systems favor standardization because common platforms simplify training, accessories, maintenance, and data integration. Growth will be driven by replacement of aging towers, expansion of outpatient rooms, and upgrades to advanced imaging and AI compatibility.
Single-use and disposable technologies are the fastest-growing technology type. This category includes procedure accessories, clips, snares, biopsy tools, needles, catheters, feeding sets, and an expanding range of single-use scopes. Disposable products offer predictable performance and reduce reprocessing requirements, but they increase per-case material cost and waste. U.S. adoption will remain procedure-specific. High-risk, low-volume, emergency, off-site, and difficult-to-reprocess applications are most favorable, while high-volume routine endoscopy will continue to use reusable systems where the economics are stronger.
Image-enhanced and AI-assisted technologies are becoming a strategic differentiator. These systems include computer-aided detection, digital contrast enhancement, multi-light imaging, lesion measurement, automated quality analytics, and structured reporting. Multiple U.S. clearances during 2024 and 2025 increased competitive choice and moved AI from a single-vendor novelty toward a broader purchasing category. Hospitals will increasingly demand evidence on false alerts, workflow impact, equitable performance, cybersecurity, software updates, and long-term cost effectiveness.
Minimally invasive therapeutic technologies include endoscopic resection, suturing, ablation, stenting, drainage, full-thickness closure, hemostasis, and metabolic endoscopy. This technology type is growing faster than routine diagnostic endoscopy because it replaces or delays surgery, shortens recovery, and supports same-session treatment. Adoption depends on physician skill and referral concentration, making training and proctoring important commercial capabilities. Products that simplify technically demanding procedures can expand the number of physicians and centers able to offer them.
Connected and software-enabled technologies are emerging across the market. Endoscopy documentation, image management, procedure analytics, equipment tracking, capsule review, manometry interpretation, remote support, and quality dashboards are becoming part of the device ecosystem. Software contributes directly to revenue through licenses and service but also protects hardware share by increasing switching costs. Integration with electronic health records and cybersecurity standards is increasingly important in enterprise purchasing.

Regional Insights: Where the Market is Growing Fastest

The U.S. Gastroenterology Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population scale, age mix, obesity and chronic disease burden, colorectal screening participation, density of gastroenterologists, concentration of academic centers, number of ASCs, and health-system capital spending. The South is the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains the most innovation-intensive region, and the Midwest provides a large, stable base of hospital and ambulatory endoscopy demand.

South

The South accounted for an estimated USD 7.16 billion in 2025 and is projected to reach approximately USD 15.62 billion by 2035. The region benefits from the largest population base, rapid growth in several metropolitan markets, a high prevalence of obesity and metabolic disease, and substantial Medicare demand. CDC state data show that the South remains one of the regions with the highest adult obesity prevalence, reinforcing demand for reflux evaluation, liver assessment, bariatric endoscopy, and management of obesity-associated GI disease.

Texas is the largest state opportunity in the region because of its population, major medical centers in Houston, Dallas–Fort Worth, Austin, and San Antonio, and continued investment in ambulatory care. Florida is another critical market due to its large older population, high colonoscopy and upper-endoscopy demand, and dense network of ASCs and physician groups. Georgia and North Carolina are expanding through population growth, academic centers, and consolidation of regional health systems. Virginia and Maryland support high-acuity demand through large integrated networks and proximity to federal and academic institutions, while the District of Columbia functions as a specialized referral and research market.

Tennessee has important healthcare headquarters, distribution capabilities, and high-volume provider systems. Kentucky, West Virginia, Alabama, Mississippi, Arkansas, Louisiana, and Oklahoma carry substantial chronic disease burdens and require a mix of tertiary-center advanced endoscopy and scalable community-based diagnostic services. South Carolina is benefiting from population growth and expanding coastal healthcare capacity. Delaware is a smaller market but participates in the Philadelphia–Baltimore referral corridor. Across the South, manufacturers must balance premium technology placement in major urban systems with service coverage, training, and affordable consumables for rural and secondary markets.

The South is expected to retain the largest share through 2035. Growth will be driven by screening of newly eligible adults, expansion of ASC capacity, obesity-related GI disease, endobariatric programs, pancreaticobiliary referral centers, and replacement of aging endoscopy infrastructure. Texas and Florida will remain the largest state markets, while North Carolina, Georgia, Tennessee, Virginia, and South Carolina are expected to gain share.

West

The West represented an estimated USD 4.06 billion in 2025 and is projected to reach approximately USD 9.03 billion by 2035, making it the fastest-growing region. The region combines major academic centers, strong digital-health adoption, a large medtech and software ecosystem, and fast-growing populations in the Mountain West. It is particularly receptive to AI-assisted endoscopy, connected documentation, advanced resection, single-use technologies, and novel metabolic procedures.

California dominates the Western market through population scale, high procedure volume, academic systems, and early adoption of advanced imaging and digital tools. Washington and Oregon have sophisticated integrated delivery networks that emphasize standardization, quality analytics, and total-cost contracting. Arizona and Nevada are expanding rapidly because of population growth and aging, supporting demand for colonoscopy, reflux testing, pancreaticobiliary care, and ambulatory endoscopy. Colorado and Utah have strong referral centers and are attractive markets for advanced therapeutic endoscopy and software-enabled platforms.

New Mexico, Idaho, Montana, and Wyoming are smaller but strategically important for regional referral networks and technologies that can extend specialty access. Alaska and Hawaii face geographic and logistics constraints that increase the value of reliable service, portable systems, single-use products, and tele-support. Across the West, purchasing decisions often incorporate sustainability, cybersecurity, interoperability, and enterprise data strategy earlier than in other regions.

The region’s growth will be supported by technology adoption, migration to outpatient care, expansion of Mountain West metropolitan areas, and demand for digitally connected care. California will remain the largest state market, while Arizona, Nevada, Colorado, Utah, and Washington are expected to show above-average expansion.

Northeast

The Northeast accounted for an estimated USD 4.45 billion in 2025 and is projected to reach approximately USD 8.91 billion by 2035. The region has the highest concentration of academic medical centers, subspecialty gastroenterologists, clinical trials, and advanced endoscopy programs. Although population growth is slower than in the South and West, procedure complexity and premium technology adoption support high revenue per facility.

New York is the largest state market in the Northeast, with major health systems, dense urban procedure volumes, and extensive ambulatory networks. Pennsylvania provides a large and diverse base across Philadelphia, Pittsburgh, and regional systems. Massachusetts is highly influential because its academic centers and research ecosystem shape adoption of AI, advanced resection, EUS-guided intervention, and novel metabolic therapies. New Jersey benefits from population density and proximity to New York and Philadelphia referral corridors.

Connecticut and Rhode Island support mature hospital and physician-group markets with high expectations for clinical evidence and service. Maine, New Hampshire, and Vermont have older populations and rural access challenges, creating demand for reliable regional referral models, enteral feeding, portable diagnostic systems, and efficient outpatient capacity. The Northeast’s procurement environment is rigorous: value-analysis committees often require comparative clinical evidence, lifecycle economics, cybersecurity review, and formal physician consensus before enterprise conversion.

The Northeast will grow slightly below the national CAGR because it is a mature market, but it will remain central to product launches, clinical evidence generation, training, and premium therapeutic adoption. Companies that achieve reference-site success in Boston, New York, Philadelphia, and major regional systems can influence purchasing decisions nationally.

Midwest

The Midwest represented an estimated USD 3.68 billion in 2025 and is projected to reach approximately USD 7.64 billion by 2035. The region offers a stable combination of large academic systems, community hospitals, physician-owned endoscopy centers, and substantial chronic disease burden. CDC data indicate that the Midwest had the highest regional adult obesity prevalence in 2024, supporting long-term demand for reflux evaluation, liver assessment, bariatric care, and metabolic-disease-related GI services.

Illinois is the largest Midwestern state market, led by Chicago’s academic and community provider ecosystem. Ohio has major referral centers and a broad network of hospitals and ASCs. Michigan supports strong demand for routine endoscopy, IBD management, hepatology, and advanced intervention. Minnesota is strategically important because of its medical-device industry, integrated delivery networks, and clinical expertise. Wisconsin and Indiana provide mature procedural markets with significant community-system purchasing power.

Missouri, Iowa, Kansas, and Nebraska support regional referral networks and stable outpatient demand. North Dakota and South Dakota are smaller markets where geographic access makes portable diagnostics, tele-support, dependable distribution, and regional center-of-excellence models particularly valuable. Across the Midwest, manufacturers often gain share through service reliability, clinical education, durable equipment, and contracting structures that work for both large systems and independent centers.

The Midwest is expected to grow steadily rather than explosively. Expansion will come from capital replacement, outpatient migration, obesity-related disease, advanced endoscopy diffusion into community systems, and consolidation of physician groups. Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, and Missouri will remain the principal state markets.

Key Market Players

The U.S. Gastroenterology Devices Competitive Landscape is moderately consolidated in endoscopy capital equipment and more fragmented in therapeutic accessories, diagnostics, enteral feeding, and emerging endobariatric technologies. Olympus, Boston Scientific, Medtronic, Fujifilm, and PENTAX Medical have broad strategic positions across visualization, therapeutic endoscopy, pancreaticobiliary intervention, AI, or related procedural ecosystems. Competition is increasingly platform-based, with leading vendors seeking to control the relationship across capital placement, disposable pull-through, service, software, training, and enterprise contracting.

Some of the key players in the U.S. Gastroenterology Devices industry are

Olympus Corporation
Boston Scientific Corporation
Medtronic
FUJIFILM Healthcare Americas Corporation
HOYA Corporation / PENTAX Medical
Ambu A/S
Cook Medical
CONMED Corporation
STERIS plc
KARL STORZ SE & Co. KG
Stryker Corporation
ERBE Elektromedizin GmbH
Micro-Tech Endoscopy USA
Merit Medical Systems, Inc.
B. Braun Melsungen AG
Teleflex Incorporated
Laborie Medical Technologies
Diversatek Healthcare
Echosens
EndoGastric Solutions, Inc.
Creo Medical Group plc
Lumendi Ltd.
Cosmo Pharmaceuticals N.V.
Iterative Health
Fractyl Health, Inc.

Market share will be influenced by installed base, FDA clearances, physician preference, repair and service performance, accessory breadth, clinical evidence, training capacity, supply reliability, and contracting flexibility. Olympus, Fujifilm, PENTAX Medical, Ambu, and KARL STORZ compete strongly in visualization and scope strategy. Boston Scientific, Cook Medical, CONMED, ERBE, Micro-Tech, Merit Medical, and Creo Medical compete across therapeutic accessories and advanced intervention. Medtronic and Cosmo are important in AI-assisted endoscopy, while Laborie and Diversatek are established in motility and reflux diagnostics. Echosens is influential in liver assessment, and EndoGastric Solutions, Lumendi, and Fractyl represent specialized innovation in reflux, advanced resection, and metabolic endoscopy.

Recent Developments

Recent developments in the U.S. Gastroenterology Devices Market show a decisive shift toward intelligent imaging, integrated platforms, and minimally invasive therapy. Olympus launched its EVIS X1 endoscopy system in the U.S. in 2023, strengthening competition around advanced image processing and enterprise platform replacement. Fujifilm expanded its U.S. portfolio with FDA-cleared CAD EYE computer-aided polyp detection and SCALE EYE lesion-measurement technology in 2024, followed by the U.S. launch of the ELUXEO 8000 platform in 2025. These developments illustrate how imaging vendors are combining hardware, software, AI, and procedural workflow rather than competing on optics alone.

The AI category broadened during 2024 and 2025 as additional computer-aided detection systems received FDA clearance. This increased buyer choice and encouraged hospitals to compare systems on clinical performance, false-positive burden, compatibility, cybersecurity, licensing, and analytics. Professional guidance published in 2025 recognized that CADe can increase polyp detection while also emphasizing the need for stronger evidence on long-term cancer outcomes, cost effectiveness, and performance across diverse settings. This will make real-world evidence and enterprise implementation support important competitive differentiators.

Portfolio consolidation has also shaped the market. Boston Scientific completed its acquisition of Apollo Endosurgery in 2023, adding endoscopic suturing and endobariatric capabilities to a broad therapeutic endoscopy business. The strategic logic reflects a wider industry trend: large medtech companies are seeking procedure platforms that combine access, visualization, therapy, closure, and follow-up rather than relying on isolated accessories.

Single-use endoscopy continues to expand selectively. Health systems are evaluating disposable scopes and components for duodenoscopy, urgent procedures, satellite sites, and high-risk patients, while retaining reusable fleets for high-volume routine cases. Adoption is increasingly based on facility-specific lifecycle economics rather than infection-control messaging alone. Reprocessing labor, repair costs, procedure volume, waste, storage, and availability all affect the decision.

Advanced therapeutic endoscopy is gaining investment as U.S. centers expand EUS-guided drainage, complex polypectomy, endoscopic submucosal dissection, full-thickness closure, and endobariatric procedures. The commercial bottleneck is no longer only device availability; it is the ability to train physicians, build referral volume, obtain coverage, and standardize post-procedure care. Vendors that combine technology with training, coding support, and outcomes data are likely to achieve faster adoption.

Conclusion

The U.S. Gastroenterology Devices Market Size & Share is positioned to expand from USD 19.35 billion in 2025 to approximately USD 41.20 billion by 2035, supported by a 7.85% CAGR during 2026–2035. The market’s durability is grounded in recurring colorectal screening, chronic digestive disease, population aging, obesity, outpatient procedure migration, and continuing innovation in minimally invasive therapy.

The most attractive growth opportunities will be found in AI-assisted and image-enhanced endoscopy, advanced therapeutic accessories, EUS and ERCP intervention, single-use devices for targeted settings, motility and reflux diagnostics, liver assessment, endoscopic bariatric therapy, connected documentation, and quality analytics. Conventional reusable endoscopy platforms will remain the largest revenue category, but future value growth will depend on software, disposables, service, and the ability to support a complete procedural ecosystem.

Regional opportunity will be led by the South because of population scale, aging, obesity burden, and ASC expansion. The West will grow fastest because of technology adoption and population growth. The Northeast will remain the leading region for advanced procedures, clinical evidence, and premium launches, while the Midwest will provide stable demand and strong replacement-cycle economics. Texas, Florida, California, New York, Pennsylvania, Illinois, Ohio, Massachusetts, North Carolina, Georgia, Arizona, Michigan, Minnesota, Tennessee, Virginia, and Washington will be especially important state markets.

For clients evaluating this market, the core issue is not whether procedure demand will rise. The strategic questions are which categories will capture value, how rapidly advanced therapy will move beyond tertiary centers, how AI and single-use technologies will alter ownership economics, and which vendors can satisfy both physician and procurement requirements. Companies that combine clinical differentiation, workflow efficiency, reimbursement support, service reliability, and real-world evidence will be best positioned to shape the U.S. gastroenterology devices market through 2035.

TABLE OF CONTENT

1. U.S. Gastroenterology Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Gastroenterology Device Manufacturers
1.6.2. Medical-Grade Component and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Gastroenterology Practices and Specialty Clinics
1.6.5. Ambulatory Surgery Centers and Endoscopy Centers
1.6.6. Group Purchasing Organizations and Medical Device Distributors
1.6.7. Payers, Regulators, Professional Societies, and Clinical Decision-Makers

What this section provides: This section defines the gastroenterology devices market boundary, study scope, methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. market is measured, segmented, and validated.

2. U.S. Gastroenterology Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.8. Key Gastroenterology Procedure and Device Adoption Indicators
2.9. Strategic Implications for Manufacturers, Providers, and Investors

What this section provides: This section gives decision-makers a concise view of market size, growth direction, major demand pockets, procedure trends, competitive intensity, and priority investment opportunities.

3. U.S. Gastroenterology Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Burden of Colorectal Cancer and Digestive Disorders
3.1.2. Expansion of Colorectal Cancer Screening and Surveillance
3.1.3. Growth in Minimally Invasive Diagnostic and Therapeutic Endoscopy
3.1.4. Increasing Prevalence of Inflammatory Bowel Disease and Chronic GI Conditions
3.1.5. Aging U.S. Population and Higher Gastrointestinal Procedure Demand
3.1.6. Migration of Endoscopy Procedures to Ambulatory Settings
3.1.7. Hospital Investment in Advanced Endoscopy and Visualization Platforms
3.1.8. Adoption of AI-Assisted Polyp Detection and Characterization
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Advanced Endoscopy Platforms
3.2.2. Reimbursement Pressure and Procedure-Level Margin Constraints
3.2.3. Endoscope Reprocessing, Infection-Control, and Cross-Contamination Risks
3.2.4. Product Recall and Device Safety Concerns
3.2.5. Gastroenterologist, Anesthesiologist, and Endoscopy Nurse Workforce Constraints
3.2.6. Uneven Access to Advanced Gastroenterology Services
3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Enabled Colonoscopy and Computer-Aided Detection
3.3.2. Single-Use and Partially Disposable Endoscopy Platforms
3.3.3. Advanced Therapeutic Endoscopy and Third-Space Procedures
3.3.4. Endoscopic Ultrasound-Guided Diagnosis and Intervention
3.3.5. Endoscopic Bariatric and Metabolic Therapies
3.3.6. Capsule Endoscopy and Wireless Diagnostic Platforms
3.3.7. Home Enteral Nutrition and Connected Feeding Systems
3.3.8. Outpatient Endoscopy Center Expansion
3.4. Challenges and Their Impact Analysis
3.4.1. Complex Device Reprocessing Requirements
3.4.2. Capital Budget Competition Within U.S. Health Systems
3.4.3. Procedure Coding and Reimbursement Variability
3.4.4. Training Requirements for Advanced Endoscopic Procedures
3.4.5. Supply-Chain Dependence for Specialized Components and Consumables
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.6.1. Procedure Room Utilization and Turnover Economics
3.6.2. Endoscope Reprocessing Labor and Consumable Costs
3.6.3. Sedation, Anesthesia, and Recovery-Room Economics
3.6.4. Disposable Versus Reusable Device Cost Comparison
3.6.5. Impact of Device Choice on Procedure Time and Throughput
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Endoscopy Tower Replacement Cycles
3.7.2. Capital Versus Operating Budget Allocation
3.7.3. Vendor Standardization Across Integrated Delivery Networks
3.7.4. Clinical Evidence and Health Economic Requirements
3.7.5. Service Contract, Maintenance, and Reprocessing Considerations

What this section provides: This section explains the clinical, commercial, reimbursement, procurement, and operational forces shaping gastroenterology device demand, helping clients evaluate growth opportunities and execution risks.

4. U.S. Gastroenterology Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.3.1. Capital Endoscopy Platform Pricing
4.3.2. Therapeutic Endoscopy Consumable Pricing
4.3.3. Gastrointestinal Stent and Dilation Device Pricing
4.3.4. Enteral Feeding Device Pricing
4.3.5. Service, Maintenance, and Reprocessing Contract Pricing
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Materials and Specialized Components
4.4.2. Device Design and Manufacturing
4.4.3. Regulatory Clearance and Quality Management
4.4.4. Distribution and Commercialization
4.4.5. Provider Procurement and Clinical Use
4.4.6. Reprocessing, Maintenance, and After-Sales Support
4.5. Impact of Digitalization and Connected Gastroenterology
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Premarket Notification and Premarket Approval Pathways
4.7.2. De Novo Classification for Novel Gastroenterology Technologies
4.7.3. Medical Device Reporting and Product Recall Requirements
4.7.4. Endoscope Reprocessing and Infection-Control Guidance
4.7.5. AI-Enabled Medical Device Regulatory Considerations
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Inpatient Prospective Payment System
4.8.2. Hospital Outpatient Prospective Payment System
4.8.3. Ambulatory Surgical Center Payment System
4.8.4. Physician Fee Schedule
4.8.5. Coverage and Coding for Advanced Gastroenterology Procedures
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Public Health Programs
4.10.1. Colorectal Cancer Screening Initiatives
4.10.2. Preventive Services Coverage Policies
4.10.3. Rural Health and Digestive Disease Access Programs
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital Value Analysis Committee Decision Framework
4.12.1. Clinical Outcomes and Procedural Safety
4.12.2. Device Acquisition and Lifecycle Cost
4.12.3. Reprocessing and Infection-Control Burden
4.12.4. Physician Preference and Training Requirements
4.12.5. Reimbursement and Contribution Margin
4.12.6. Vendor Service and Supply-Chain Reliability

What this section provides: This section gives clients a complete view of the regulatory, reimbursement, pricing, supply-chain, technology, and procurement environment influencing the U.S. gastroenterology devices industry.

5. U.S. Gastroenterology Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Endoscopy Systems and Visualization Equipment
5.1.2.1. Video Endoscopes
5.1.2.2. Colonoscopes
5.1.2.3. Gastroscopes
5.1.2.4. Duodenoscopes
5.1.2.5. Enteroscopes
5.1.2.6. Endoscopic Ultrasound Systems
5.1.2.7. Endoscopy Video Processors and Light Sources
5.1.2.8. Endoscopy Imaging and Display Systems
5.1.3. Endoscopic Therapeutic Devices and Accessories
5.1.3.1. Biopsy Forceps
5.1.3.2. Polypectomy Snares
5.1.3.3. Hemostasis Clips and Closure Devices
5.1.3.4. Injection Needles
5.1.3.5. Guidewires and Access Devices
5.1.3.6. Retrieval Baskets and Nets
5.1.3.7. Endoscopic Suturing and Tissue-Aposition Devices
5.1.3.8. Ablation and Electrosurgical Devices
5.1.3.9. Endoscopic Mucosal Resection and Dissection Devices
5.1.4. Gastrointestinal Stents, Dilation, and Decompression Devices
5.1.4.1. Esophageal Stents
5.1.4.2. Biliary Stents
5.1.4.3. Pancreatic Stents
5.1.4.4. Colonic and Duodenal Stents
5.1.4.5. Balloon Dilators
5.1.4.6. Bougie Dilators
5.1.4.7. Decompression Tubes and Drainage Devices
5.1.5. Enteral Feeding and Gastrostomy Devices
5.1.5.1. Gastrostomy Tubes
5.1.5.2. Jejunostomy Tubes
5.1.5.3. Nasoenteric Feeding Tubes
5.1.5.4. Enteral Feeding Pumps
5.1.5.5. Feeding Sets, Connectors, and Accessories
5.1.5.6. Low-Profile Feeding Devices
5.1.6. Gastrointestinal Diagnostic, Motility, and Capsule Endoscopy Devices
5.1.6.1. Capsule Endoscopy Systems
5.1.6.2. Esophageal Manometry Systems
5.1.6.3. Anorectal Manometry Systems
5.1.6.4. Ambulatory pH Monitoring Systems
5.1.6.5. Impedance Monitoring Systems
5.1.6.6. Breath Testing Devices
5.1.6.7. GI Functional Diagnostic Catheters and Accessories

What this section provides: This section identifies which gastroenterology device categories are expected to generate the highest revenue contribution, procedure utilization, recurring consumable demand, and growth through 2035.

6. U.S. Gastroenterology Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Colorectal Cancer Screening, Detection, and Surveillance
6.1.2.1. Screening Colonoscopy
6.1.2.2. Polyp Detection and Removal
6.1.2.3. Tissue Biopsy and Pathology Sampling
6.1.2.4. Post-Treatment Surveillance
6.1.3. Biliary and Pancreatic Disease Management
6.1.3.1. Endoscopic Retrograde Cholangiopancreatography
6.1.3.2. Biliary Stone Extraction
6.1.3.3. Biliary and Pancreatic Stenting
6.1.3.4. Endoscopic Ultrasound-Guided Diagnosis
6.1.3.5. Endoscopic Ultrasound-Guided Drainage and Intervention
6.1.4. Gastrointestinal Bleeding and Therapeutic Endoscopy
6.1.4.1. Non-Variceal Bleeding Management
6.1.4.2. Variceal Bleeding Management
6.1.4.3. Endoscopic Clipping and Coagulation
6.1.4.4. Endoscopic Suturing and Defect Closure
6.1.4.5. Foreign-Body Removal
6.1.5. Inflammatory Bowel Disease and Lower Gastrointestinal Disorders
6.1.5.1. Crohn’s Disease
6.1.5.2. Ulcerative Colitis
6.1.5.3. Diverticular Disease
6.1.5.4. Lower GI Strictures and Obstruction
6.1.5.5. Small-Bowel Disease Evaluation
6.1.6. Obesity, GERD, Nutrition, Motility, and Other GI Disorders
6.1.6.1. Endoscopic Bariatric and Metabolic Procedures
6.1.6.2. Gastroesophageal Reflux Disease Management
6.1.6.3. Enteral Nutrition and Feeding Access
6.1.6.4. Dysphagia and Esophageal Disorders
6.1.6.5. Motility and Functional GI Disorders
6.1.6.6. Other Diagnostic and Therapeutic Gastroenterology Applications

What this section provides: This section helps clients understand gastroenterology device demand by clinical use case and prioritize applications with strong procedure growth, reimbursement relevance, and innovation potential.

7. U.S. Gastroenterology Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Academic Medical Centers
7.1.2.2. Community Hospitals
7.1.2.3. Tertiary and Quaternary Referral Hospitals
7.1.2.4. Integrated Delivery Networks
7.1.3. Ambulatory Surgery Centers and Dedicated Endoscopy Centers
7.1.3.1. Hospital-Owned ASCs
7.1.3.2. Physician-Owned ASCs
7.1.3.3. Corporate and Private Equity-Backed Endoscopy Platforms
7.1.3.4. Independent Endoscopy Centers
7.1.4. Gastroenterology Clinics and Physician Practices
7.1.4.1. Independent Gastroenterology Practices
7.1.4.2. Multispecialty Physician Groups
7.1.4.3. Hospital-Affiliated Gastroenterology Practices
7.1.5. Specialty Diagnostic and Advanced Therapeutic Centers
7.1.5.1. Motility and Functional GI Laboratories
7.1.5.2. Inflammatory Bowel Disease Centers
7.1.5.3. Pancreaticobiliary and Advanced Endoscopy Centers
7.1.5.4. Bariatric and Metabolic Endoscopy Centers
7.1.6. Home Healthcare and Long-Term Care Providers
7.1.6.1. Home Enteral Nutrition Providers
7.1.6.2. Skilled Nursing Facilities
7.1.6.3. Long-Term Acute Care Facilities
7.1.6.4. Home Infusion and Durable Medical Equipment Providers

What this section provides: This section explains which care settings and customer groups are expected to drive capital equipment purchases, procedure adoption, disposable-device consumption, and recurring enteral-care demand.

8. U.S. Gastroenterology Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Flexible Video, High-Definition, and 4K Endoscopy Technologies
8.1.2.1. Standard-Definition Video Endoscopy
8.1.2.2. High-Definition Endoscopy
8.1.2.3. 4K and Ultra-High-Definition Visualization
8.1.2.4. Narrow-Band and Enhanced Imaging
8.1.3. Endoscopic Ultrasound, ERCP, and Image-Guided Technologies
8.1.3.1. Radial Endoscopic Ultrasound
8.1.3.2. Linear Endoscopic Ultrasound
8.1.3.3. ERCP Imaging and Navigation
8.1.3.4. Cholangioscopy and Pancreatoscopy
8.1.4. Capsule, Wireless, and AI-Assisted Diagnostic Technologies
8.1.4.1. Small-Bowel Capsule Endoscopy
8.1.4.2. Colon Capsule Endoscopy
8.1.4.3. Computer-Aided Polyp Detection
8.1.4.4. Computer-Aided Lesion Characterization
8.1.4.5. Cloud-Enabled Image Management and Reporting
8.1.5. Single-Use and Disposable Endoscopy Technologies
8.1.5.1. Single-Use Duodenoscopes
8.1.5.2. Single-Use Gastroscopes and Colonoscopes
8.1.5.3. Disposable Endoscope Components
8.1.5.4. Single-Use Therapeutic Accessories
8.1.6. Therapeutic, Robotic, and Computer-Assisted Endoscopy Technologies
8.1.6.1. Endoscopic Suturing and Closure Platforms
8.1.6.2. Endoscopic Submucosal Dissection Platforms
8.1.6.3. Third-Space Endoscopy Technologies
8.1.6.4. Robotic and Mechanically Assisted Endoscopy
8.1.6.5. Endoluminal Bariatric Technologies

What this section provides: This section evaluates the technology platforms reshaping gastroenterology care, including advanced imaging, AI, disposable endoscopy, image-guided intervention, and therapeutic endoluminal systems.

9. U.S. Gastroenterology Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Tenders
9.1.2.2. Consumable and Procedure-Pack Contracts
9.1.2.3. Service and Maintenance Agreements
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Enterprise Vendor Standardization
9.1.3.2. Multi-Year Portfolio Agreements
9.1.3.3. System-Wide Technology Conversion Programs
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Contracts
9.1.4.2. Regional GPO Contracts
9.1.4.3. Aggregated Ambulatory Purchasing Programs
9.1.5. Distributor and Specialty Supplier Sales
9.1.5.1. National Medical-Surgical Distributors
9.1.5.2. Specialty Gastroenterology Distributors
9.1.5.3. Home Enteral Nutrition and DME Distribution
9.1.6. Ambulatory and Physician-Practice Procurement
9.1.6.1. Independent ASC Purchasing
9.1.6.2. Physician-Owned Endoscopy Center Procurement
9.1.6.3. Management Services Organization Procurement
9.1.6.4. Corporate Endoscopy Platform Procurement

What this section provides: This section explains how gastroenterology devices are purchased in the U.S., including hospital contracting, IDN standardization, GPO influence, distributor participation, and ambulatory procurement behavior.

10. U.S. Gastroenterology Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Gastroenterology Procedure Volume Analysis
10.1.4. Regional Hospital, ASC, and Endoscopy Center Infrastructure Analysis
10.1.5. Regional Digestive Disease and Colorectal Cancer Burden
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Technology Adoption and Competitive Intensity

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Gastroenterology Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, gastroenterology procedure-volume hubs, screening markets, technology-adoption hotspots, and state-level commercial opportunities.

11. U.S. Gastroenterology Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Strategy Analysis
11.3.1. Endoscopy Platform Competition
11.3.2. Therapeutic Device Portfolio Competition
11.3.3. Capital Equipment and Consumable Bundling
11.3.4. Hospital and IDN Contracting Strategies
11.3.5. Physician Training and Clinical Education
11.3.6. Mergers, Acquisitions, Partnerships, and Licensing
11.4. Company Profiles
11.4.1. Olympus Corporation
11.4.2. Boston Scientific Corporation
11.4.3. Medtronic
11.4.4. FUJIFILM Holdings Corporation
11.4.5. HOYA Corporation – PENTAX Medical
11.4.6. Stryker Corporation
11.4.7. Ambu A/S
11.4.8. Cook Medical
11.4.9. CONMED Corporation
11.4.10. STERIS plc
11.4.11. KARL STORZ SE & Co. KG
11.4.12. B. Braun Melsungen AG
11.4.13. BD
11.4.14. Cardinal Health
11.4.15. Merit Medical Systems
11.4.16. Laborie Medical Technologies
11.4.17. Diversatek Healthcare
11.4.18. Avanos Medical
11.4.19. ERBE Elektromedizin GmbH
11.4.20. Micro-Tech Endoscopy USA
11.4.21. Taewoong Medical USA
11.4.22. Creo Medical Group
11.4.23. EndoGastric Solutions
11.4.24. Echosens
11.4.25. Motus GI Holdings

Note: Each company profile will include company overview, gastroenterology device portfolio, U.S. market strategy, financial and commercial positioning, clinical pipeline, FDA and regulatory updates, partnerships, acquisitions, product launches, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, innovation direction, commercial strategy, and intelligence on major gastroenterology device companies.

12. U.S. Gastroenterology Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Assisted Polyp Detection and Lesion Characterization
12.2.2. Single-Use and Disposable Endoscopy Platforms
12.2.3. Advanced Therapeutic and Third-Space Endoscopy
12.2.4. Robotic and Computer-Assisted Endoluminal Procedures
12.2.5. Endoscopic Ultrasound-Guided Intervention
12.2.6. Capsule Endoscopy and Wireless Diagnostics
12.2.7. Connected Enteral Feeding and Home-Care Technologies
12.3. Emerging Business Trends
12.3.1. Consolidation of Gastroenterology Practices
12.3.2. Private Equity Investment in Ambulatory Endoscopy
12.3.3. Capital Equipment-as-a-Service Models
12.3.4. Outcome-Based and Utilization-Linked Contracting
12.3.5. Integration of Capital Systems, Consumables, and Software
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.5.1. Market Attractiveness
12.5.2. Clinical Unmet Need
12.5.3. Reimbursement Potential
12.5.4. Competitive Intensity
12.5.5. Regulatory Complexity
12.5.6. Commercial Scalability

What this section provides: This section prepares clients for future technology shifts, changes in care delivery, investment opportunities, competitive disruption, and adoption scenarios through 2035.

13. U.S. Gastroenterology Devices Market: Strategic Recommendations

13.1. Recommendations for Gastroenterology Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Delivery Networks
13.3. Recommendations for Gastroenterology Practices and Endoscopy Centers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. Go-to-Market Strategy Considerations
13.7.1. Target-Customer Prioritization
13.7.2. Regional Commercial Deployment
13.7.3. Physician Education and Key Opinion Leader Development
13.7.4. Reimbursement and Health Economic Support
13.7.5. IDN, GPO, and ASC Contracting Strategy
13.8. Product Positioning and Portfolio Expansion Guidance
13.8.1. Capital Equipment Portfolio Strategy
13.8.2. Recurring Consumable Revenue Strategy
13.8.3. Single-Use Technology Positioning
13.8.4. AI and Software Commercialization
13.8.5. Advanced Therapeutic Endoscopy Expansion
13.9. Market Entry and Competitive Differentiation Framework

What this section provides: This section converts market intelligence into actionable recommendations for growth planning, product positioning, channel expansion, investment decisions, market entry, and competitive differentiation.

14. U.S. Gastroenterology Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Market Definition and Revenue Attribution Disclaimer
14.7. Company and Competitive Intelligence Disclaimer
14.8. Regulatory and Reimbursement Information Disclaimer

What this section provides: This section clarifies the report’s scope limitations, forecasting assumptions, legal boundaries, data-use terms, revenue-attribution methodology, and third-party information limitations.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Gastroenterology Devices Market: Market Definition and Scope
TABLE 3: U.S. Gastroenterology Devices Market: Research Methodology Framework
TABLE 4: U.S. Gastroenterology Devices Market: Key Assumptions
TABLE 5: U.S. Gastroenterology Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Gastroenterology Devices Market: Stakeholder Analysis
TABLE 7: U.S. Gastroenterology Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Gastroenterology Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Gastroenterology Devices Market: Market Attractiveness Index
TABLE 10: U.S. Gastroenterology Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Gastroenterology Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Gastroenterology Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Gastroenterology Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Gastroenterology Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Gastroenterology Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Gastroenterology Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Gastroenterology Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Gastroenterology Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Gastroenterology Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Gastroenterology Devices Market: PESTEL Analysis
TABLE 21: U.S. Gastroenterology Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Gastroenterology Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Gastroenterology Devices Market: Value Chain Analysis
TABLE 24: U.S. Gastroenterology Devices Market: Supply Chain Analysis
TABLE 25: U.S. Gastroenterology Devices Market: Digitalization and Connected Gastroenterology Impact
TABLE 26: U.S. Gastroenterology Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Gastroenterology Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Gastroenterology Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Gastroenterology Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Gastroenterology Devices Market: Government Initiatives and Public Health Programs
TABLE 31: U.S. Gastroenterology Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Gastroenterology Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 33: U.S. Gastroenterology Devices Market: Product Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Category
TABLE 35: U.S. Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Gastroenterology Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 37: U.S. Gastroenterology Devices Market: Endoscopy Systems and Visualization Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Gastroenterology Devices Market: Endoscopic Therapeutic Devices and Accessories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Gastroenterology Devices Market: Gastrointestinal Stents, Dilation, and Decompression Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Gastroenterology Devices Market: Enteral Feeding and Gastrostomy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Gastroenterology Devices Market: Gastrointestinal Diagnostic, Motility, and Capsule Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Gastroenterology Devices Market: Application Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Application
TABLE 44: U.S. Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 45: U.S. Gastroenterology Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 46: U.S. Gastroenterology Devices Market: Colorectal Cancer Screening, Detection, and Surveillance Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Gastroenterology Devices Market: Biliary and Pancreatic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Gastroenterology Devices Market: Gastrointestinal Bleeding and Therapeutic Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Gastroenterology Devices Market: Inflammatory Bowel Disease and Lower Gastrointestinal Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Gastroenterology Devices Market: Obesity, GERD, Nutrition, Motility, and Other GI Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Gastroenterology Devices Market: End User Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by End User
TABLE 53: U.S. Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 54: U.S. Gastroenterology Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 55: U.S. Gastroenterology Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Gastroenterology Devices Market: Ambulatory Surgery Centers and Dedicated Endoscopy Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Gastroenterology Devices Market: Gastroenterology Clinics and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Gastroenterology Devices Market: Specialty Diagnostic and Advanced Therapeutic Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Gastroenterology Devices Market: Home Healthcare and Long-Term Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Gastroenterology Devices Market: Technology Type Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 62: U.S. Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 63: U.S. Gastroenterology Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 64: U.S. Gastroenterology Devices Market: Flexible Video, High-Definition, and 4K Endoscopy Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Gastroenterology Devices Market: Endoscopic Ultrasound, ERCP, and Image-Guided Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Gastroenterology Devices Market: Capsule, Wireless, and AI-Assisted Diagnostic Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Gastroenterology Devices Market: Single-Use and Disposable Endoscopy Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Gastroenterology Devices Market: Therapeutic, Robotic, and Computer-Assisted Endoscopy Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Gastroenterology Devices Market: Procurement Channel Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 71: U.S. Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 72: U.S. Gastroenterology Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 73: U.S. Gastroenterology Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Gastroenterology Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Gastroenterology Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Gastroenterology Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Gastroenterology Devices Market: Ambulatory and Physician-Practice Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Gastroenterology Devices Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Gastroenterology Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Gastroenterology Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Gastroenterology Devices Market: Regional Overview and Trends
TABLE 83: West Region U.S. Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 84: West Region U.S. Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 90: California Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 91: California Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 92: California Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 93: California Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 94: California Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 95: Washington Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 96: Washington Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 97: Washington Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: Washington Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 99: Washington Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 100: Arizona Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 101: Arizona Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 102: Arizona Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 103: Arizona Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 104: Arizona Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: Colorado Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 106: Colorado Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 107: Colorado Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: Colorado Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 109: Colorado Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 110: Oregon Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 111: Oregon Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 112: Oregon Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 113: Oregon Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 114: Oregon Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 115: Utah Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 116: Utah Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Utah Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Utah Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 119: Utah Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: Nevada Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 121: Nevada Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 122: Nevada Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Nevada Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 124: Nevada Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 125: New Mexico Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: Idaho Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 131: Idaho Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: Idaho Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: Idaho Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 134: Idaho Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: Montana Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 136: Montana Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 137: Montana Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 138: Montana Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 139: Montana Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: Wyoming Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Alaska Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 146: Alaska Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 147: Alaska Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 148: Alaska Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 149: Alaska Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 150: Hawaii Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 155: Northeast Region U.S. Gastroenterology Devices Market: Regional Overview and Trends
TABLE 156: Northeast Region U.S. Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 157: Northeast Region U.S. Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Northeast Region U.S. Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: New York Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 164: New York Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: New York Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 166: New York Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 167: New York Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 168: Massachusetts Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 173: New Jersey Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 178: Pennsylvania Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 183: Connecticut Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 188: Maine Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 189: Maine Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 190: Maine Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 191: Maine Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 192: Maine Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 193: Vermont Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 194: Vermont Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 195: Vermont Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 196: Vermont Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 197: Vermont Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 198: New Hampshire Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 203: Rhode Island Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 208: Delaware Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 209: Delaware Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 210: Delaware Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 211: Delaware Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 212: Delaware Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 213: South Region U.S. Gastroenterology Devices Market: Regional Overview and Trends
TABLE 214: South Region U.S. Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 215: South Region U.S. Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 216: South Region U.S. Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 217: South Region U.S. Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 221: Texas Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 222: Texas Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 223: Texas Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 224: Texas Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 225: Texas Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 226: Florida Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 227: Florida Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 228: Florida Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 229: Florida Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 230: Florida Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 231: Georgia Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 232: Georgia Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 233: Georgia Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 234: Georgia Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 235: Georgia Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 236: North Carolina Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 237: North Carolina Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 241: Tennessee Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 242: Tennessee Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 246: South Carolina Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 247: South Carolina Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 251: Alabama Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 252: Alabama Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 253: Alabama Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 254: Alabama Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 255: Alabama Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 256: Mississippi Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 257: Mississippi Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 261: Louisiana Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 262: Louisiana Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 266: Arkansas Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 267: Arkansas Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 271: Kentucky Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 272: Kentucky Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 276: Oklahoma Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 277: Oklahoma Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 281: Virginia Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 282: Virginia Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 283: Virginia Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 284: Virginia Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 285: Virginia Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 286: Maryland Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 287: Maryland Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 288: Maryland Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 289: Maryland Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 290: Maryland Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 291: West Virginia Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 296: Midwest Region U.S. Gastroenterology Devices Market: Regional Overview and Trends
TABLE 297: Midwest Region U.S. Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 298: Midwest Region U.S. Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 299: Midwest Region U.S. Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 300: Midwest Region U.S. Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 304: Illinois Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 305: Illinois Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 306: Illinois Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 307: Illinois Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 308: Illinois Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 309: Ohio Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 310: Ohio Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: Ohio Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: Ohio Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 313: Ohio Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 314: Michigan Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 315: Michigan Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 316: Michigan Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 317: Michigan Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 318: Michigan Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 319: Minnesota Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 320: Minnesota Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 321: Minnesota Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 322: Minnesota Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 323: Minnesota Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 324: Indiana Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 325: Indiana Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 326: Indiana Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 327: Indiana Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 328: Indiana Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 329: Wisconsin Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 330: Wisconsin Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 331: Wisconsin Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 332: Wisconsin Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 333: Wisconsin Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 334: Missouri Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 335: Missouri Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 336: Missouri Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 337: Missouri Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 338: Missouri Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 339: Iowa Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 340: Iowa Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 341: Iowa Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 342: Iowa Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 343: Iowa Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 344: Kansas Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 345: Kansas Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 346: Kansas Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 347: Kansas Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 348: Kansas Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 349: Nebraska Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 350: Nebraska Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 351: Nebraska Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 352: Nebraska Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 353: Nebraska Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 354: North Dakota Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 355: North Dakota Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 356: North Dakota Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 357: North Dakota Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 358: North Dakota Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 359: South Dakota Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 360: South Dakota Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 361: South Dakota Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 362: South Dakota Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 363: South Dakota Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 364: U.S. Gastroenterology Devices Market: Competitive Landscape Snapshot, 2025
TABLE 365: U.S. Gastroenterology Devices Market: Key Company Market Share Analysis, 2025
TABLE 366: U.S. Gastroenterology Devices Market: Company Positioning Matrix
TABLE 367: U.S. Gastroenterology Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 368: U.S. Gastroenterology Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 369: Olympus Corporation: Company Profile
TABLE 370: Boston Scientific Corporation: Company Profile
TABLE 371: Medtronic: Company Profile
TABLE 372: FUJIFILM Holdings Corporation: Company Profile
TABLE 373: HOYA Corporation – PENTAX Medical: Company Profile
TABLE 374: Stryker Corporation: Company Profile
TABLE 375: Ambu A/S: Company Profile
TABLE 376: Cook Medical: Company Profile
TABLE 377: CONMED Corporation: Company Profile
TABLE 378: STERIS plc: Company Profile
TABLE 379: KARL STORZ SE & Co. KG: Company Profile
TABLE 380: B. Braun Melsungen AG: Company Profile
TABLE 381: BD: Company Profile
TABLE 382: Cardinal Health: Company Profile
TABLE 383: Merit Medical Systems: Company Profile
TABLE 384: Laborie Medical Technologies: Company Profile
TABLE 385: Diversatek Healthcare: Company Profile
TABLE 386: Avanos Medical: Company Profile
TABLE 387: ERBE Elektromedizin GmbH: Company Profile
TABLE 388: Micro-Tech Endoscopy USA: Company Profile
TABLE 389: Taewoong Medical USA: Company Profile
TABLE 390: Creo Medical Group: Company Profile
TABLE 391: EndoGastric Solutions: Company Profile
TABLE 392: Echosens: Company Profile
TABLE 393: Motus GI Holdings: Company Profile
TABLE 394: U.S. Gastroenterology Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 395: U.S. Gastroenterology Devices Market: Disruptive Technologies Impact Matrix
TABLE 396: U.S. Gastroenterology Devices Market: Emerging Business Trends
TABLE 397: U.S. Gastroenterology Devices Market: Business Opportunities for Startups and Existing Players
TABLE 398: U.S. Gastroenterology Devices Market: Investment Prioritization Matrix
TABLE 399: U.S. Gastroenterology Devices Market: Strategic Recommendations for Gastroenterology Device Manufacturers
TABLE 400: U.S. Gastroenterology Devices Market: Strategic Recommendations for Hospitals and Integrated Delivery Networks
TABLE 401: U.S. Gastroenterology Devices Market: Strategic Recommendations for Gastroenterology Practices and Endoscopy Centers
TABLE 402: U.S. Gastroenterology Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 403: U.S. Gastroenterology Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 404: U.S. Gastroenterology Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 405: U.S. Gastroenterology Devices Market: Go-to-Market Strategy Considerations
TABLE 406: U.S. Gastroenterology Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 407: U.S. Gastroenterology Devices Market: Market Entry and Competitive Differentiation Framework
TABLE 408: U.S. Gastroenterology Devices Market: Scope Limitation
TABLE 409: U.S. Gastroenterology Devices Market: Data Use Limitation
TABLE 410: U.S. Gastroenterology Devices Market: Forecasting Limitation
TABLE 411: U.S. Gastroenterology Devices Market: Legal Disclaimer
TABLE 412: U.S. Gastroenterology Devices Market: Third-Party Data Disclaimer
TABLE 413: U.S. Gastroenterology Devices Market: Market Definition and Revenue Attribution Disclaimer
TABLE 414: U.S. Gastroenterology Devices Market: Company and Competitive Intelligence Disclaimer
TABLE 415: U.S. Gastroenterology Devices Market: Regulatory and Reimbursement Information Disclaimer

List of Figures

FIGURE 1: U.S. Gastroenterology Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Gastroenterology Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Gastroenterology Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Endoscopy Systems and Visualization Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Endoscopic Therapeutic Devices and Accessories Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Gastrointestinal Stents, Dilation, and Decompression Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Enteral Feeding and Gastrostomy Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Gastrointestinal Diagnostic, Motility, and Capsule Endoscopy Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 23: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Colorectal Cancer Screening, Detection, and Surveillance Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Biliary and Pancreatic Disease Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Gastrointestinal Bleeding and Therapeutic Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Inflammatory Bowel Disease and Lower Gastrointestinal Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Obesity, GERD, Nutrition, Motility, and Other GI Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 30: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Ambulatory Surgery Centers and Dedicated Endoscopy Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Gastroenterology Clinics and Physician Practices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Specialty Diagnostic and Advanced Therapeutic Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Home Healthcare and Long-Term Care Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 37: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Flexible Video, High-Definition, and 4K Endoscopy Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Endoscopic Ultrasound, ERCP, and Image-Guided Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Capsule, Wireless, and AI-Assisted Diagnostic Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Single-Use and Disposable Endoscopy Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Therapeutic, Robotic, and Computer-Assisted Endoscopy Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Ambulatory and Physician-Practice Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: West Region U.S. Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 53: West Region Market Share Analysis by State, 2025
FIGURE 54: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: California Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Washington Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Arizona Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Colorado Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Oregon Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Utah Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Nevada Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New Mexico Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Idaho Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Montana Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Wyoming Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Alaska Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Hawaii Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Northeast Region U.S. Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Maine Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Vermont Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Hampshire Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Rhode Island Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Delaware Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: South Region U.S. Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Texas Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Florida Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Georgia Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: North Carolina Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Tennessee Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Carolina Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Alabama Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Mississippi Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Louisiana Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Arkansas Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Kentucky Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Oklahoma Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Virginia Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Maryland Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: West Virginia Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Midwest Region U.S. Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 100: Midwest Region Market Share Analysis by State, 2025
FIGURE 101: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Illinois Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Ohio Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Michigan Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Minnesota Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Indiana Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Wisconsin Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Missouri Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Iowa Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Kansas Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Nebraska Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: North Dakota Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: South Dakota Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 115: Company Positioning Matrix
FIGURE 116: Key Player Product Portfolio Benchmarking
FIGURE 117: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 118: Gastroenterology Device Innovation Roadmap
FIGURE 119: AI-Assisted Endoscopy Adoption Roadmap
FIGURE 120: Single-Use Endoscopy Technology Opportunity Map
FIGURE 121: Advanced Therapeutic Endoscopy Growth Roadmap
FIGURE 122: Future Market Scenario Analysis, 2026–2035
FIGURE 123: Disruptive Technologies Impact Matrix
FIGURE 124: Emerging Business Trends Matrix
FIGURE 125: Investment Prioritization Matrix
FIGURE 126: Strategic Growth Roadmap for U.S. Gastroenterology Device Companies
FIGURE 127: Go-to-Market Strategy Framework
FIGURE 128: Product Positioning and Portfolio Expansion Framework
FIGURE 129: Report Scope and Disclaimer Framework